Kurt C. Wheeler
Managing Director
pharmaceutical sciences
avillion
Netherlands
Biography
Managing Director of Clarus Ventures since the firm’s inception in 2005 after being a General Partner at MPM Capital, a healthcare venture capital firm. Over 30 years of direct investment and industry experience within the healthcare sector. Founder and CEO of InControl, a medical device company sold to Guidant, previously he was a Principal with the Mayfield Fund focused on healthcare investing. BA from Brigham Young University, and a MBA from Northwestern University’s Kellogg School. Represents Clarus Ventures on the Board of Directors of Globus (NYSE:GMED), Flowonix, SFJ Pharmaceutical and Avillion LLP. Prior Investments include Hemosense acquired by Inverness Medical, Intrathrerapeutics acquired by Sulzer Medica, Eyetech Pharmaceuticals, SenoRx acquired by CR Bard, Neuromed Pharmaceuticals, CHF Solutions acquired by Gambro, Somaxon Pharmaceuticals and Zogenix.
Research Interest
